Europe PMCopen access
Long-term microbiome and clinical effects of a microbiome-guided personalized diet versus low-FODMAP diet in irritable bowel syndrome: A 12-month follow-up randomized controlled trial
Artificial intelligence, alpha diversity, irritable bowel syndrome, Microbiome, 16s Rrna Sequencing, Randomized Trial
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 676379
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.